Literature DB >> 27841860

Medication nonadherence to immunosuppressants after adult allogeneic haematopoietic stem cell transplantation: a multicentre cross-sectional study.

B Gresch1, M Kirsch2, K Fierz3, J P Halter4, G Nair4, K Denhaerynck3, S De Geest3,5.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27841860     DOI： 10.1038/bmt.2016.262

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  13 in total

Review 1.  The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review.

Authors:  Fabienne Dobbels; Lut Berben; Sabina De Geest; Gerda Drent; Annette Lennerling; Clare Whittaker; Christiane Kugler
Journal:  Transplantation       Date:  2010-07-27       Impact factor: 4.939

Review 2.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

3.  Exploring chronic myeloid leukemia patients' reasons for not adhering to the oral anticancer drug imatinib as prescribed.

Authors:  Lina Eliasson; Sarah Clifford; Nick Barber; David Marin
Journal:  Leuk Res       Date:  2010-11-20       Impact factor: 3.156

4.  Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the Integrative Model of Behavioral Prediction: a cross-sectional study.

Authors:  Gabriela Schmid-Mohler; Martina Pechula Thut; Rudolf Peter Wüthrich; Kris Denhaerynck; Sabina De Geest
Journal:  Clin Transplant       Date:  2009-08-11       Impact factor: 2.863

Review 5.  Surviving the cure: long term followup of hematopoietic cell transplant recipients.

Authors:  N S Majhail; J Douglas Rizzo
Journal:  Bone Marrow Transplant       Date:  2013-01-07       Impact factor: 5.483

6.  Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study.

Authors:  M Kirsch; A Götz; J P Halter; U Schanz; G Stussi; F Dobbels; S De Geest
Journal:  Bone Marrow Transplant       Date:  2014-07-21       Impact factor: 5.483

7.  Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia.

Authors:  Prasanth Ganesan; Tenali Gnana Sagar; Biswajit Dubashi; Rejiv Rajendranath; Krishnarathinam Kannan; Sanju Cyriac; Manjunath Nandennavar
Journal:  Am J Hematol       Date:  2011-04-27       Impact factor: 10.047

8.  Medication-taking among adult renal transplant recipients: barriers and strategies.

Authors:  Elisa J Gordon; Mary Gallant; Ashwini R Sehgal; David Conti; Laura A Siminoff
Journal:  Transpl Int       Date:  2009-01-16       Impact factor: 3.782

Review 9.  Graft-versus-host disease: why have we not made more progress?

Authors:  Samantha M Jaglowski; Steven M Devine
Journal:  Curr Opin Hematol       Date:  2014-03       Impact factor: 3.284

10.  Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force.

Authors:  R F Duarte; H Greinix; B Rabin; S A Mitchell; G Basak; D Wolff; J A Madrigal; S Z Pavletic; S J Lee
Journal:  Bone Marrow Transplant       Date:  2013-08-19       Impact factor: 5.483
View more
  7 in total

1.  Cost Utility of Lifelong Immunoglobulin Replacement Therapy vs Hematopoietic Stem Cell Transplant to Treat Agammaglobulinemia.

Authors:  Di Sun; Jennifer R Heimall; Matthew J Greenhawt; Nancy J Bunin; Marcus S Shaker; Neil Romberg
Journal:  JAMA Pediatr       Date:  2022-02-01       Impact factor: 16.193

2.  Rates and Predictors of Nonadherence to the Post-Allogeneic Hematopoietic Cell Transplantation Medical Regimen in Patients and Caregivers.

Authors:  Donna M Posluszny; Dana H Bovbjerg; Karen L Syrjala; Mounzer Agha; Rafic Farah; Jing-Zhou Hou; Anastasios Raptis; Annie P Im; Kathleen A Dorritie; Michael M Boyiadzis; Mary Amanda Dew
Journal:  Transplant Cell Ther       Date:  2021-12-04

3.  Exploring Stem Cell Transplanted Patients' Perspectives on Medication Self-Management and Electronic Monitoring Devices Measuring Medication Adherence: A Qualitative Sub-Study of the Swiss SMILe Implementation Science Project.

Authors:  Janette Ribaut; Sabina De Geest; Lynn Leppla; Sabine Gerull; Alexandra Teynor; Sabine Valenta
Journal:  Patient Prefer Adherence       Date:  2022-01-06       Impact factor: 2.711

4.  The SMILe integrated care model in allogeneic SteM cell TransplantatIon faciLitated by eHealth: a protocol for a hybrid effectiveness-implementation randomised controlled trial.

Authors:  Sabina De Geest; Sabine Valenta; Lynn Leppla; Alexandra Teynor; Janette Ribaut; Sabine Gerull; Juliane Mielke; Michael Simon; Jana Bartakova; Klaus Kaier; Jens Eckstein
Journal:  BMC Health Serv Res       Date:  2022-08-20       Impact factor: 2.908

5.  Unraveling implementation context: the Basel Approach for coNtextual ANAlysis (BANANA) in implementation science and its application in the SMILe project.

Authors:  Juliane Mielke; Lynn Leppla; Sabine Valenta; Leah L Zullig; Franziska Zúñiga; Sandra Staudacher; Alexandra Teynor; Sabina De Geest
Journal:  Implement Sci Commun       Date:  2022-10-01

6.  Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: the SMILe implementation science project.

Authors:  Janette Ribaut; Lynn Leppla; Alexandra Teynor; Sabine Valenta; Fabienne Dobbels; Leah L Zullig; Sabina De Geest
Journal:  BMC Health Serv Res       Date:  2020-09-02       Impact factor: 2.655

7.  Development of an integrated model of care for allogeneic stem cell transplantation facilitated by eHealth-the SMILe study.

Authors:  Lynn Leppla; Anja Schmid; Sabine Valenta; Juliane Mielke; Sonja Beckmann; Janette Ribaut; Alexandra Teynor; Fabienne Dobbels; Nathalie Duerinckx; Robert Zeiser; Monika Engelhardt; Sabine Gerull; Sabina De Geest
Journal:  Support Care Cancer       Date:  2021-07-05       Impact factor: 3.603
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.